Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Neuroendocrine Tumors × Metformin × Clear all

Phase

Phase EARLY_PHASE1 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1 Endocrine 1

Conditions

Prostatic Neoplasms 21 Breast Neoplasms 18 Carcinoma, Non-Small-Cell Lung 11 Polycystic Ovary Syndrome 9 Colorectal Neoplasms 9 Lung Neoplasms 8 Pancreatic Neoplasms 6 Endometrial Neoplasms 6 Neoplasms 5 Glioblastoma 5 Lymphoma, Large B-Cell, Diffuse 4 Adenocarcinoma of Lung 4 Adenocarcinoma 4 Rectal Neoplasms 3 Melanoma 3 Leukoplakia, Oral 3 Insulin Resistance 3 Uterine Cervical Neoplasms 2 Urinary Bladder Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Neoplasm Metastasis 2 Liver Neoplasms 2 Leukemia, Myeloid, Acute 2 Hyperandrogenism 2 Esophageal Neoplasms 2 Erythroplasia 2 Diabetes Mellitus 2 Carcinoma, Ovarian Epithelial 2 Carcinoma, Hepatocellular 2 Brain Neoplasms 2

Interventions

lutetium Lu 177 dotatate 15 Everolimus 10 Temozolomide 9 Nivolumab 8 Capecitabine 7 pembrolizumab 6 cabozantinib 5 Sunitinib 5 lanreotide 4 gallium Ga 68 dotatate 4 177Lu-octreotide, DOTA(0)-Tyr(3)- 4 telotristat ethyl 3 pazopanib 3 lenvatinib 3 avelumab 3 Octreotide 3 Magnetic Resonance Spectroscopy 3 Ipilimumab 3 Injections 3 Etoposide 3 Cyclophosphamide 3 Carboplatin 3 Bevacizumab 3 surufatinib 2 sintilimab 2 fosbretabulin 2 fludarabine 2 Specimen Handling 2 Positron Emission Tomography Computed Tomography 2 Pemetrexed 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02279758 2014-10-31

MetNet

Instituto do Cancer do Estado de São Paulo

Phase 2 Unknown

Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡